Cite
HARVARD Citation
Mallardo, D. et al. (2022). Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis. Journal for immunotherapy of cancer. 10 (11), p. . [Online].